Supernus Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/4/2026 | 653 | 0.0% | 13,145 | 12/31/2025 |
| 2025 Q3 | 10/24/2025 | 602 | 0.0% | 12,598 | 9/30/2025 |
| 2025 Q2 | 7/25/2025 | 403 | 0.0% | 12,798 | 6/30/2025 |
| 2025 Q1 | 4/28/2025 | 416 | 0.0% | 12,698 | 3/31/2025 |
| 2024 Q4 | 2/5/2025 | 470 | 0.0% | 12,998 | 12/31/2024 |
| 2024 Q3 | 10/29/2024 | 405 | 0.0% | 12,998 | 9/30/2024 |
| 2024 Q2 | 8/2/2024 | 356 | 0.0% | 13,298 | 6/30/2024 |
| 2024 Q1 | 5/3/2024 | 498 | 0.0% | 14,598 | 3/31/2024 |
| 2023 Q4 | 2/12/2024 | 463 | 0.0% | 15,998 | 12/31/2023 |
| 2023 Q3 | 10/27/2023 | 448 | 0.0% | 16,253 | 9/30/2023 |
| 2023 Q2 | 7/26/2023 | 510 | 0.0% | 16,953 | 6/30/2023 |
| 2023 Q1 | 5/4/2023 | 629 | 0.0% | 17,353 | 3/31/2023 |
| 2022 Q4 | 1/26/2023 | 628 | 0.0% | 17,603 | 12/31/2022 |
| 2022 Q3 | 11/2/2022 | 597 | 0.0% | 17,633 | 9/30/2022 |
| 2022 Q2 | 7/25/2022 | 503 | 0.0% | 17,408 | 6/30/2022 |
| 2022 Q1 | 4/21/2022 | 650 | 0.0% | 20,108 | 3/31/2022 |
| 2021 Q4 | 2/1/2022 | 601 | 0.0% | 20,608 | 12/31/2021 |
| 2021 Q3 | 10/19/2021 | 576 | 0.0% | 21,608 | 9/30/2021 |
| 2021 Q2 | 7/23/2021 | 668 | 0.0% | 21,708 | 6/30/2021 |
| 2021 Q1 | 4/20/2021 | 568 | 0.0% | 21,708 | 3/31/2021 |
| 2020 Q4 | 2/9/2021 | 536 | 0.0% | 21,308 | 12/31/2020 |
| 2020 Q3 | 11/3/2020 | 451 | 0.0% | 21,639 | 9/30/2020 |
| 2020 Q2 | 7/21/2020 | 500 | 0.0% | 21,039 | 6/30/2020 |
| 2020 Q1 | 4/20/2020 | 378 | 0.0% | 21,039 | 3/31/2020 |
| 2019 Q4 | 2/5/2020 | 499 | 0.0% | 21,039 | 12/31/2019 |